Airway Hyperreactivity.- Airway hyperreactivity, an introduction.- An alternative point of view on experimental lung hyperreactivity.- Isolated and dual type of late asthmatic response (LAR) The clinical characteristics and pharmacologic control.- Delayed asthmatic response (DAR) and its pharmacologic modulation.- Cytologic changes in the nasal secretions (NS) during the immediate (INR) and late nasal response (LNR) to allergen challenge (NPT).- Airway diameter determines flow-resistance and sensitivity to contractile mediators in perfused bronchial segments..- Modulating effects of antiasthmatic and antitussive drugs on autonomic neurotransmission in guinea-pig bronchial muscle in vitro.- Effect of subacute exposure to nitrogen dioxide on the airway responsiveness of guinea pig.- Tocoxara canis-induced airway hyporeactivity in mice.- Plasticisers, another burden for asthmatics ?.- Inflammatory Cells and Mediators.- Eicosanoids and inflammatory cells in asthma.- The effect of prostanoids on the function of human eosinophils.- Modulation of guinea pig airway reactivity by the linoleic acid metabolite, 13-hydroxy-octadecadienoic acid (13-HODE).- The effects of drugs on lung hyperreactivity in sephadex treated rats.- Adenyl cyclase activity in human alveolar macrophages.- Activated human granulocytes contract isolated human airways.- Pulmonary surfactant secretion in type II pneumocytes in inflamed condition.- Superoxide production by broncho-alveolar cells is diminished in parainfluenza-3 virus treated guinea pigs.- Oxidative stress and receptor responses in guinea-pig tracheal tissue.- Cytokines.- Cytokines and bronchial hyperreactivity.- Effect of lymphokines on ?-adrenoceptor stimulation of human PBMC.- A role for T cells in the induction of airway hyperreactivity.- Peptides.- Neuropeptides as modulators of airway function.- Modulation of cholinergic neurotransmission by VIP, VIP-antiserum and VIP-antagonists in dog and cat trachea: VIP plays a role of double brl“9